Clearasil acne treatment

Clearasil (commonly misspelled as "Clerasil") — product identity and origin

Clearasil is a long-established medicated acne-care brand originally developed in the United States in 1950 by Ivan Combe (Combe Incorporated). It was introduced as a targeted skin-care product for teenage acne and has since expanded into a broad line of topical acne treatments and cleansers. (en.wikipedia.org)

Manufacturing and regional production

Clearasil products are manufactured in multiple countries to serve regional markets; label and regulatory filings show production and packaging from sites in the United States, France and Brazil (and regional variants are also produced in markets such as Japan), so manufacturing is regionally distributed rather than single‑country only. This regional manufacturing approach supports local supply chains and market-specific formulations and packaging. (fda.report)

Brand ownership and distribution

The Clearasil brand changed hands several times (Combe → Richardson‑Vicks → Procter & Gamble → Boots Group) and is currently part of Reckitt's portfolio after Reckitt acquired Boots Healthcare International; Reckitt (trading simply as "Reckitt") remains the ultimate owner and global steward of the Clearasil brand, with regional distribution managed through Reckitt subsidiaries such as RB Health (US). Reckitt is headquartered in the United Kingdom and operates Clearasil as one of its global skin‑care/OTC offerings. (reckitt.com)